Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbiome of the Eye01:22

Microbiome of the Eye

62
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
62
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

2
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
2
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

3
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
3
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

73
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
73
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

70
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
70
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

71
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of different microbes and pathogenic factors in cases of infectious bovine keratoconjunctivitis in cattle from Eastern Kazakhstan.

Veterinary world·2023
Same author

Randomized controlled field trial to assess the efficacy of an intranasal <i>Moraxella bovis</i> cytotoxin vaccine against naturally occurring infectious bovine keratoconjunctivitis.

Vaccine: X·2023
Same author

Effects of eye patches on corneal ulcer healing and weight gain in stocker steers on pasture: a randomized controlled trial.

Translational animal science·2021
Same author

Bovine Immune Responses to Moraxella bovis and Moraxella bovoculi Following Vaccination and Natural or Experimental Infections.

The Veterinary clinics of North America. Food animal practice·2021
Same author

Future Directions for Research in Infectious Bovine Keratoconjunctivitis.

The Veterinary clinics of North America. Food animal practice·2021
Same author

Relatedness of type IV pilin PilA amongst geographically diverse <i>Moraxella bovoculi</i> isolated from cattle with infectious bovine keratoconjunctivitis.

Journal of medical microbiology·2021

Related Experiment Video

Updated: Apr 18, 2026

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
09:22

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

Published on: May 12, 2020

6.4K

Infectious bovine keratoconjunctivitis (pinkeye).

John A Angelos1

  • 1Department of Medicine and Epidemiology, University of California, 2108 Tupper Hall, Davis, CA 95616, USA.

The Veterinary Clinics of North America. Food Animal Practice
|January 11, 2015
PubMed
Summary

Effective infectious bovine keratoconjunctivitis (IBK) control requires integrated strategies addressing host, environment, and management. Ongoing research explores new treatments and the roles of various bacteria in IBK pathogenesis.

Keywords:
Infectious bovine keratoconjunctivitisMoraxella bovisMoraxella bovoculiPinkeyePreventionTreatment

More Related Videos

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
07:24

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis

Published on: February 6, 2021

13.5K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K

Related Experiment Videos

Last Updated: Apr 18, 2026

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
09:22

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

Published on: May 12, 2020

6.4K
Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
07:24

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis

Published on: February 6, 2021

13.5K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K

Area of Science:

  • Veterinary Ophthalmology
  • Infectious Disease Control
  • Bovine Health

Background:

  • Infectious bovine keratoconjunctivitis (IBK) is a significant concern in cattle farming.
  • Current control strategies for IBK involve host, environmental, and herd management factors.
  • Established antibiotic treatments exist, but new etiological questions are emerging.

Purpose of the Study:

  • To review the multifaceted approach to controlling infectious bovine keratoconjunctivitis (IBK).
  • To highlight the evolution of understanding regarding the causative agents of IBK.
  • To address the implications of recent discoveries on IBK pathogenesis and treatment.

Main Methods:

  • Literature review of IBK research over many years.
  • Analysis of established antibiotic treatments and regimens.
  • Examination of recent findings on Mor bovoculi and Mycoplasma spp. in IBK.

Main Results:

  • Successful IBK control necessitates a holistic approach including host, environment, herd management, and surveillance.
  • A variety of effective antibiotic treatments have been identified.
  • New research indicates potential roles for Mor bovoculi and Mycoplasma spp. in IBK, distinct from previous understandings.

Conclusions:

  • Integrated management and surveillance are crucial for long-term IBK control.
  • Antibiotic therapies remain a cornerstone of IBK treatment.
  • Further research is needed to elucidate the complex roles of various microorganisms in IBK pathogenesis.